Multivariable model . | Significant parameters for multivariable logistic regression . | Multivariable logistic regression, P-value . | AUC with cross-validation . | AIC . |
---|---|---|---|---|
1. Step AIC model | AREXAmide,0.625µT | 0.013 (*) | 0.75 | 178.95 |
AREXNOE,0.625µT | 0.008 (**) | |||
1/(RA·T2A) | 0.004 (**) | |||
T1 | 0.004 (**) | |||
2. Step AIC model with PCA | MTRAsym,0.625µT | 0.014 (*) | 0.71 | 178.94 |
1/(RA·T2A) | 0.030 (*) | |||
Multivariable analysis including perfusion rCBV with multiple imputation | ||||
3. Step AIC model | 1/(RA·T2A) | 0.012 (*) | 0.67 [0.67, 0.67] | N/A |
T1 | 0.028 (*) | |||
AREXAmide,0.625µT | 0.047 (*) | |||
AREXNOE,0.625µT | 0.026 (*) | |||
4. Step AIC model with PCA | 1/(RA·T2A) | 0.017 (*) | 0.67 [0.65, 0.69] | N/A |
Multivariable model . | Significant parameters for multivariable logistic regression . | Multivariable logistic regression, P-value . | AUC with cross-validation . | AIC . |
---|---|---|---|---|
1. Step AIC model | AREXAmide,0.625µT | 0.013 (*) | 0.75 | 178.95 |
AREXNOE,0.625µT | 0.008 (**) | |||
1/(RA·T2A) | 0.004 (**) | |||
T1 | 0.004 (**) | |||
2. Step AIC model with PCA | MTRAsym,0.625µT | 0.014 (*) | 0.71 | 178.94 |
1/(RA·T2A) | 0.030 (*) | |||
Multivariable analysis including perfusion rCBV with multiple imputation | ||||
3. Step AIC model | 1/(RA·T2A) | 0.012 (*) | 0.67 [0.67, 0.67] | N/A |
T1 | 0.028 (*) | |||
AREXAmide,0.625µT | 0.047 (*) | |||
AREXNOE,0.625µT | 0.026 (*) | |||
4. Step AIC model with PCA | 1/(RA·T2A) | 0.017 (*) | 0.67 [0.65, 0.69] | N/A |
Multivariable logistic regression was performed with and without perfusion rCBV values included. Principal component analysis (PCA) was used to reduce the AREX and MTR parameters in Model 2, whereas Model 1 used all the individual MT/CEST variables as input. Where rCBV was included (ie, Models 3 and 4), multiple imputation was used to deal with missing data. Significant parameters and values are bolded, and asterisks (*) and (**) indicate P-values below .05 and .01, respectively. For AUCs with multiple imputation and cross-validation, the 1st and 3rd quartile are shown in brackets.
Multivariable model . | Significant parameters for multivariable logistic regression . | Multivariable logistic regression, P-value . | AUC with cross-validation . | AIC . |
---|---|---|---|---|
1. Step AIC model | AREXAmide,0.625µT | 0.013 (*) | 0.75 | 178.95 |
AREXNOE,0.625µT | 0.008 (**) | |||
1/(RA·T2A) | 0.004 (**) | |||
T1 | 0.004 (**) | |||
2. Step AIC model with PCA | MTRAsym,0.625µT | 0.014 (*) | 0.71 | 178.94 |
1/(RA·T2A) | 0.030 (*) | |||
Multivariable analysis including perfusion rCBV with multiple imputation | ||||
3. Step AIC model | 1/(RA·T2A) | 0.012 (*) | 0.67 [0.67, 0.67] | N/A |
T1 | 0.028 (*) | |||
AREXAmide,0.625µT | 0.047 (*) | |||
AREXNOE,0.625µT | 0.026 (*) | |||
4. Step AIC model with PCA | 1/(RA·T2A) | 0.017 (*) | 0.67 [0.65, 0.69] | N/A |
Multivariable model . | Significant parameters for multivariable logistic regression . | Multivariable logistic regression, P-value . | AUC with cross-validation . | AIC . |
---|---|---|---|---|
1. Step AIC model | AREXAmide,0.625µT | 0.013 (*) | 0.75 | 178.95 |
AREXNOE,0.625µT | 0.008 (**) | |||
1/(RA·T2A) | 0.004 (**) | |||
T1 | 0.004 (**) | |||
2. Step AIC model with PCA | MTRAsym,0.625µT | 0.014 (*) | 0.71 | 178.94 |
1/(RA·T2A) | 0.030 (*) | |||
Multivariable analysis including perfusion rCBV with multiple imputation | ||||
3. Step AIC model | 1/(RA·T2A) | 0.012 (*) | 0.67 [0.67, 0.67] | N/A |
T1 | 0.028 (*) | |||
AREXAmide,0.625µT | 0.047 (*) | |||
AREXNOE,0.625µT | 0.026 (*) | |||
4. Step AIC model with PCA | 1/(RA·T2A) | 0.017 (*) | 0.67 [0.65, 0.69] | N/A |
Multivariable logistic regression was performed with and without perfusion rCBV values included. Principal component analysis (PCA) was used to reduce the AREX and MTR parameters in Model 2, whereas Model 1 used all the individual MT/CEST variables as input. Where rCBV was included (ie, Models 3 and 4), multiple imputation was used to deal with missing data. Significant parameters and values are bolded, and asterisks (*) and (**) indicate P-values below .05 and .01, respectively. For AUCs with multiple imputation and cross-validation, the 1st and 3rd quartile are shown in brackets.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.